Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 9/20 | 0.58 |
| ▸ | NPY4R | P50391 | 8/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.58 |
| ▸ | NPY1R | P25929 | 7/20 | 0.58 |
| ▸ | TFPI | P10646 | 7/20 | 0.56 |
| ▸ | VIPR1 | P32241 | 2/20 | 0.53 |
| ▸ | VIPR2 | P41587 | 1/20 | 0.53 |
| ▸ | GLP1R | P43220 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10014808 | 0.83 | TFPI (0.49) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL29399759 | 0.76 | NPY2R (0.89) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL30121639 | 0.75 | NPY2R (0.92) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL15669203 | 0.75 | NPY2R (0.74) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL30397368 | 0.75 | NPY2R (0.82) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL15669269 | 0.74 | NPY2R (0.76) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL4331434 | 0.74 | NPY2R (0.75) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL30735721 | 0.74 | NPY2R (0.77) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL29436010 | 0.74 | NPY2R (0.77) | NPY2RNPY4RNPY5RNPY1RTFPI | |
| SCHEMBL29411681 | 0.74 | NPY2R (0.72) | NPY2RNPY4RNPY5RNPY1RTFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120039843-A1 | CONJUGATES OF A POLYPEPTIDE AND AN OLIGOSACCHARIDE | N.V. ORGANON (NL) | 2012-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120039843-A1 | CONJUGATES OF A POLYPEPTIDE AND AN OLIGOSACCHARIDE | SERPINC1, SELP, F13B | NPY2R 811/4885NPY4R 424/4885NPY5R 921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.